The effects of cardioplegia washout on myocardial preservation.
Preservation of the myocardium in vitro is more effective than preservation in vitro when preservation conditions are apparently the same. The washout of cardioplegia from the myocardium by noncoronary blood flow has been implicated as a probable cause of the poorer myocardial preservation seen in vivo. Isolated dog hearts were used to study the effects of cardioplegia washout by low flow perfusion (0.05 ml/min/g LV weight) during a 2-hr preservation period. Six experimental groups of five hearts each underwent 2 hr of myocardial preservation at temperatures of 20 degrees C (three groups) or 30 degrees C (three groups). The three groups for each temperature consisted of retrograde coronary sinus perfusion (to simulate cardioplegia washout by collateral flow) with blood cardioplegia (BC), normal blood (NB), or no perfusion at all (No CSP). The quality of preservation in each group was assessed by measuring recovery of left ventricular function, tissue water and electrolyte content, and myocardial high-energy phosphate and adenylate content prior to, during, and following preservation. In hearts maintained at 20 degrees C, cardioplegia washout did not significantly affect left ventricular function or myocardial levels of H2O, Na, K, ATP, or total adenylates. When myocardial temperature was allowed to increase to 30 degrees C, preservation was better with low flow perfusion during the preservation period. Hearts warmed to 30 degrees C with no cardioplegia washout experienced a 50% loss of tissue ATP levels and recovered less than 30% of normal left ventricular function during a 150-min reperfusion period. In contrast, hearts slowly perfused during the preservation period maintained nearly normal levels of ATP and returned to normal function by 150 min of reperfusion. Although myocardial warming by noncoronary perfusion has a detrimental effect on myocardial preservation, the slow washout of cardioplegia per se has no apparent detrimental effect on preservation.
D000227:Adenine Nucleotides / Q000378:metabolism; D000818:Animals; D001011:Aorta; D001769:Blood; D001834:Body Water / Q000378:metabolism; D003250:Constriction; D004285:Dogs; D006324:Heart Arrest, Induced / Q000379:methods*; D006325:Heart Atria; D066298:In Vitro Techniques; D009200:Myocardial Contraction; D009206:Myocardium / Q000378:metabolism*; D009926:Organ Preservation / Q000379:methods*; D010477:Perfusion; D011188:Potassium / Q000378:metabolism; D012039:Regional Blood Flow; D012964:Sodium / Q000378:metabolism; D012996:Solutions; D013997:Time Factors
D000227:Adenine Nucleotides; D012996:Solutions; D012964:Sodium; D011188:Potassium